Abstract
Lung cancer appears to be an obvious priority for screening programs, according to many of the well-known evaluative criteria [1]. It is currently the most common cancer worldwide, both in terms of annual numbers of cases [2] and deaths [3]. Survival from lung cancer is poor — only about 12% for men in the United States [4], rather lower (8%) in European centers [5], and even worse in developing countries [6], Several early attempts were made to screen for lung cancer in uncontrolled projects that mainly relied upon regular chest x-rays — for example examinations every six months in the Veterans Administration study [7], the Philadelphia Pulmonary Neoplasm Research Project [8], and the South London Lung Cancer Study [9]. These, and the more recent controlled studies referred to below, confirmed that regular chest x-ray examination could detect tumors that were at an earlier stage (smaller and with less spread), and that these had better survival than cancers detected following clinical presentation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Wilson JM, Junger G. 1968. Principles and Practice of Screening for Disease. Public Health Papers No. 34. Geneva: WHO.
Parkin DM, Pisani P, Ferlay J. 1993. Estimates of the worldwide incidence of eighteen major cancers in 1985. Int J Cancer 54:594–606.
Pisani P, Parkin DM, Ferlay J. 1993. Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer 55:891–903.
Ries LAG, Miller BA, Hankey BF, Kosary CL, Harras A, Edwards BK (eds.). 1994. SEER Cancer Statistics Review, 1973–1991. NIH Publication No. 94-2789. Bethesda, MD: National Cancer Institute.
Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T, Esteve J. 1995. Survival of Cancer Patients in Europe: The EUROCARE Study (IARC Sci. Publ. No. 132). Lyon: International Agency for Research on Cancer.
Sriamporn S, Black RJ, Sankaranarayanan R, Kamsa-ad S, Parkin DM, Vatanasapt V. 1995. Cancer survival in Khon Kaen Province, Thailand. Int J Cancer 61:296–300.
Lilienfeld A, Archer PG, Burnett CH, Chamberlain EW, Chazin BJ, Davies D, Davis RL, Haber PA, Hodges FJ, Koprowska I, Kordan B, Lane JT, Lawton AH, Lee L, MacCallum DB, McDonald JR, Milder JW, Naylor B, Papanicolaou GN, Slutzker B, Smith RT, Swepston ER, Umiker WO. 1966. An evaluation of radiologic and cytologic screening for the early detection of lung cancer: A Cooperative Pilot Study of the American Cancer Society and the Veterans Administration. Cancer Res 26:2083–2121.
Boucot KR, Weiss KR. 1973. Is curable lung cancer detected by semi-annual screening? JAMA 22:1361–1365.
Nash FA, Morgan JM, Tomkins JG. 1968. South London lung cancer study. Br Med J ii:715–721.
Mulshine JL, Tockman MS, Smart CR. 1989. Considerations in the development of lung cancer screening tools. J Natl Cancer Inst 81:900–906.
Cole P, Morrison AS. 1978. Basic issues in cancer screening. In Miller AB (ed.), Screening in Cancer, UICC Technical Report Series, vol. 40. Geneva: International Union Against Cancer, pp. 7–39.
Morrison AS. 1985. Screening in chronic disease. New York, Oxford: Oxford University Press.
Flehinger BJ, Melamed MR, Zaman MB, Heelan RT, Kimmel M, Perchick WB, Martini N. 1984. Screening for early detection of lung cancer in New York. In Prorok PC, Miller AB (eds.), Screening for Cancer, UICC Technical Report Series, vol. 78. Geneva: International Union Against Cancer, pp. 123–135.
Melamed MR, Flehinger BJ, Zaman MB, Heelan RT, Perchick WA, Martini N. 1984. Screening for early lung cancer. Results of the Memorial Sloan-Kettering Study in New York. Chest 86:44–53.
Tockman MS, Levin LM, Frost JK, Ball WC, Stitik FP, Marsh BR. 1985. Screening and detection of lung cancer. In Aisner J. (ed.), Lung Cancer: Contemporary Issues in Clinical Oncology, vol. 3. New York: Churchill Livingstone, pp. 25–40.
Ebeling K, Nischan P. 1987. Screening for lung cancer — results from a case-control study. Int J Cancer 40:141–144.
Berndt R, Nischan P, Ebeling K. 1990. Screening for lung cancer in the middle-aged. Int J Cancer 45:229–230.
Sobue T, Suzuki T, Naruke T, and the Japanese Lung-Cancer-Screening Research Group. 1992. A case-control study for evaluating lung-cancer screening in Japan. Int J Cancer 50:230–237.
Connor RJ, Prorok PC, Weeds DC. 1991. The case-control design and the measurement of the efficacy of cancer screening. J Clin Epidemiol 44:1215–1221.
Moss SM. 1991. Case-control studies of screening. Int J Epidemiol 20:1–6.
Weiss NS, McKnight B, Stevens NG. 1992. Approaches to the analysis of case-control studies of the efficacy of screening for cancer. Am J Epidemiol 135:817–823.
Wilde J. 1989. A 10-year follow-up of semi-annual screening for early detection of lung cancer in the Erfurt County, GDR. Eur Respir J 2:656–662.
Friedman GD, Collen MF, Fireman BH. 1986. Multiphasic health checkup evaluation: a 16-year follow-up. J Chron Dis 39:453–463.
Fontana RS. 1984. Early detection of lung cancer; the Mayo project. In Prorok PC, Miller AB (eds.), Screening for Cancer. UICC Technical Report Series, vol. 78. Geneva: International Union Against Cancer, pp. 107–122.
Fontana RS, Sanderson DR, Woolner LB, Taylor WF, Miller WE, Muhm JR, Bernatz PE, Payne WS, Pairolero PC, Bergstralh EJ. 1991. Screening for Lung Cancer. A critique of the Mayo Lung Project. Cancer 67:1155–1164.
Brett GZ. 1968. The value of lung cancer detection by six-monthly chest radiographs. Thorax 23:414–420.
Brett GZ. 1996. Earlier diagnosis and survival in lung cancer. Br Med J 4:260–262.
Kubik A, Parkin DM, Khlat M, Erban J, Polak J, Adamec M. 1990. Lack of benefit from semiannual screening for cancer of the lung: follow-up report of a randomized controlled trial on a population of high-risk males in Czechoslovakia. Int J Cancer 45:26–33.
Delendi M, Riboli E, Peruzzo P, Stanta G, Cocchi A, Gardiman D, Sasco AJ, Giarelli L. 1991. Comparison of diagnoses of cancers of the respiratory system on death certificates and at autopsy. In Riboli E, Dedendi M (eds.), Autopsy in Epidemiology and Medical Research (IARC Sci. Publ. No. 112). Lyon: International Agency for Research on Cancer, pp. 55–62.
McFarlane MJ, Feinstein AR, Wells CK, Chan CK. 1987. The “Epidemiologic Necropsy”. JAMA 258:331–338.
Cameron HM. 1991. The role of the autopsy in assessing clinical diagnosis. In Riboli E, Delendi M (eds.), Autopsy in Epidemiology and Medical Research (IARC Sci. Publ. No. 112). Lyon: International Agency for Research on Cancer, pp. 75–79.
Strauss GM, Gleason RE, Sugarbaker DJ. 1993. Screening for lung cancer re-examined. A reinterpretation of the Mayo Lung Project. Randomized Trial on Lung Cancer Screening. Chest 103:337S-345S.
Smart CR. 1993. Annual screening using chest X-ray examination for the diagnosis of lung cancer. Cancer 72:2295–2298.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers
About this chapter
Cite this chapter
Parkin, D.M., Pisani, P. (1996). Screening for lung cancer. In: Miller, A.B. (eds) Advances in Cancer Screening. Cancer Treatment and Research, vol 86. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1265-9_9
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1265-9_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8539-7
Online ISBN: 978-1-4613-1265-9
eBook Packages: Springer Book Archive